Mayne Pharma Group Ltd
ASX:MYX
Wall Street
Price Targets
MYX Price Targets Summary
Mayne Pharma Group Ltd
According to Wall Street analysts, the average 1-year price target for
MYX
is 7.18 AUD
with a low forecast of 6.76 AUD and a high forecast of 7.75 AUD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MYX's stock price target?
Price Target
7.18
AUD
According to Wall Street analysts, the average 1-year price target for
MYX
is 7.18 AUD
with a low forecast of 6.76 AUD and a high forecast of 7.75 AUD.
What is Mayne Pharma Group Ltd's Revenue forecast?
Projected CAGR
38%
For the last 5 years the
compound annual growth rate for
Mayne Pharma Group Ltd's revenue is
-19%.
The projected
CAGR
for the next 3 years is
38%.
What is Mayne Pharma Group Ltd's Net Income forecast?
Projected CAGR
-46%
The
compound annual growth rate
of Mayne Pharma Group Ltd's net income for the next 3 years is
-46%.
You don't have any saved screeners yet
